(Q84818442)
Statements
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck (English)
R Hitt
A Irigoyen
H Cortes-Funes
J J Grau
J J Cruz-Hernandez
Spanish Head and Neck Cancer Cooperative Group (TTCC)
23 August 2011